Kestra Private Wealth Services LLC Has $862,000 Stake in Humana Inc. (NYSE:HUM)

Kestra Private Wealth Services LLC boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 9.3% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,883 shares of the insurance provider’s stock after purchasing an additional 160 shares during the period. Kestra Private Wealth Services LLC’s holdings in Humana were worth $862,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of HUM. Mariner LLC increased its stake in shares of Humana by 2.3% in the 3rd quarter. Mariner LLC now owns 14,119 shares of the insurance provider’s stock valued at $6,869,000 after buying an additional 312 shares during the period. Massachusetts Financial Services Co. MA increased its stake in shares of Humana by 27.5% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 27,943 shares of the insurance provider’s stock valued at $13,595,000 after buying an additional 6,034 shares during the period. Silverarc Capital Management LLC acquired a new stake in shares of Humana in the 3rd quarter valued at $4,865,000. Vest Financial LLC increased its stake in shares of Humana by 43.3% in the 4th quarter. Vest Financial LLC now owns 27,993 shares of the insurance provider’s stock valued at $12,815,000 after buying an additional 8,455 shares during the period. Finally, Artemis Investment Management LLP increased its stake in shares of Humana by 9.6% in the 4th quarter. Artemis Investment Management LLP now owns 64,573 shares of the insurance provider’s stock valued at $29,563,000 after buying an additional 5,672 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. StockNews.com lowered Humana from a “strong-buy” rating to a “hold” rating in a research report on Friday, January 26th. The Goldman Sachs Group reduced their price target on Humana from $450.00 to $385.00 and set a “buy” rating on the stock in a research report on Wednesday, April 3rd. Raymond James assumed coverage on Humana in a research report on Friday, March 22nd. They issued a “market perform” rating on the stock. Oppenheimer reduced their price target on Humana from $415.00 to $370.00 and set an “outperform” rating on the stock in a research report on Thursday, April 25th. Finally, TD Cowen reduced their price target on Humana from $427.00 to $396.00 and set a “buy” rating on the stock in a research report on Tuesday, April 2nd. Eleven analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, Humana has an average rating of “Hold” and an average price target of $424.50.

Humana Trading Down 0.1 %

Shares of HUM stock opened at $320.54 on Friday. The company’s fifty day simple moving average is $324.12 and its two-hundred day simple moving average is $388.34. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.67 and a quick ratio of 1.67. Humana Inc. has a 1 year low of $298.61 and a 1 year high of $541.21. The stock has a market capitalization of $38.63 billion, a price-to-earnings ratio of 19.96, a PEG ratio of 1.86 and a beta of 0.49.

Humana (NYSE:HUM) last released its quarterly earnings results on Wednesday, April 24th. The insurance provider reported $7.23 earnings per share for the quarter, topping the consensus estimate of $6.12 by $1.11. The firm had revenue of $29.61 billion for the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.82% and a return on equity of 17.76%. The business’s quarterly revenue was up 10.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $9.38 earnings per share. As a group, analysts anticipate that Humana Inc. will post 16.18 earnings per share for the current year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be given a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.54 annualized dividend and a yield of 1.10%. Humana’s dividend payout ratio (DPR) is presently 22.04%.

Insider Buying and Selling

In other Humana news, Director Jorge S. Mesquita purchased 545 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was acquired at an average cost of $367.09 per share, for a total transaction of $200,064.05. Following the completion of the transaction, the director now directly owns 2,578 shares in the company, valued at approximately $946,358.02. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 0.32% of the stock is owned by company insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.